495 related articles for article (PubMed ID: 30576500)
21. Bidirectional Mendelian randomization to explore the causal relationships between body mass index and polycystic ovary syndrome.
Brower MA; Hai Y; Jones MR; Guo X; Chen YI; Rotter JI; Krauss RM; Legro RS; Azziz R; Goodarzi MO
Hum Reprod; 2019 Jan; 34(1):127-136. PubMed ID: 30496407
[TBL] [Abstract][Full Text] [Related]
22. Childhood, adolescent, and adulthood adiposity are associated with risk of PCOS: a Mendelian randomization study with meta-analysis.
Dobbie LJ; Pittam B; Zhao SS; Alam U; Hydes TJ; Barber TM; Cuthbertson DJ
Hum Reprod; 2023 Jun; 38(6):1168-1182. PubMed ID: 37015099
[TBL] [Abstract][Full Text] [Related]
23. Young women with polycystic ovary syndrome have raised levels of circulating annexin V-positive platelet microparticles.
Willis GR; Connolly K; Ladell K; Davies TS; Guschina IA; Ramji D; Miners K; Price DA; Clayton A; James PE; Rees DA
Hum Reprod; 2014 Dec; 29(12):2756-63. PubMed ID: 25336711
[TBL] [Abstract][Full Text] [Related]
24. Recommendations for epidemiologic and phenotypic research in polycystic ovary syndrome: an androgen excess and PCOS society resource.
Azziz R; Kintziger K; Li R; Laven J; Morin-Papunen L; Merkin SS; Teede H; Yildiz BO
Hum Reprod; 2019 Nov; 34(11):2254-2265. PubMed ID: 31751476
[TBL] [Abstract][Full Text] [Related]
25. Evolution of metabolic alterations 5 Years after early puberty in a cohort of girls predisposed to polycystic ovary syndrome.
Harnois-Leblanc S; Trottier A; Leblanc S; Battista MC; Geller DH; Baillargeon JP
Reprod Biol Endocrinol; 2017 Jul; 15(1):56. PubMed ID: 28738839
[TBL] [Abstract][Full Text] [Related]
26. Angiotensin II type 2 receptor stimulation improves fatty acid ovarian uptake and hyperandrogenemia in an obese rat model of polycystic ovary syndrome.
Leblanc S; Battista MC; Noll C; Hallberg A; Gallo-Payet N; Carpentier AC; Vine DF; Baillargeon JP
Endocrinology; 2014 Sep; 155(9):3684-93. PubMed ID: 24971613
[TBL] [Abstract][Full Text] [Related]
27. Serum lipoprotein lipid profile in women with the polycystic ovary syndrome: relation to anthropometric, endocrine and metabolic variables.
Holte J; Bergh T; Berne C; Lithell H
Clin Endocrinol (Oxf); 1994 Oct; 41(4):463-71. PubMed ID: 7955457
[TBL] [Abstract][Full Text] [Related]
28. Hyperglycemia-induced oxidative stress is independent of excess abdominal adiposity in normal-weight women with polycystic ovary syndrome.
González F; Sia CL; Shepard MK; Rote NS; Minium J
Hum Reprod; 2012 Dec; 27(12):3560-8. PubMed ID: 22940766
[TBL] [Abstract][Full Text] [Related]
29. Overweight and obese but not normal weight women with PCOS are at increased risk of Type 2 diabetes mellitus-a prospective, population-based cohort study.
Ollila MM; West S; Keinänen-Kiukaanniemi S; Jokelainen J; Auvinen J; Puukka K; Ruokonen A; Järvelin MR; Tapanainen JS; Franks S; Piltonen TT; Morin-Papunen LC
Hum Reprod; 2017 Feb; 32(2):423-431. PubMed ID: 28031324
[TBL] [Abstract][Full Text] [Related]
30. Dyslipidaemia is associated with insulin resistance in women with polycystic ovaries.
Robinson S; Henderson AD; Gelding SV; Kiddy D; Niththyananthan R; Bush A; Richmond W; Johnston DG; Franks S
Clin Endocrinol (Oxf); 1996 Mar; 44(3):277-84. PubMed ID: 8729522
[TBL] [Abstract][Full Text] [Related]
31. Insulin action in women with polycystic ovary syndrome and its relation to gestational diabetes.
de Wilde MA; Goverde AJ; Veltman-Verhulst SM; Eijkemans MJ; Franx A; Fauser BC; Koster MP
Hum Reprod; 2015 Jun; 30(6):1447-53. PubMed ID: 25840428
[TBL] [Abstract][Full Text] [Related]
32. The correlation of plasma omentin-1 with insulin resistance in non-obese polycystic ovary syndrome.
Yang HY; Ma Y; Lu XH; Liang XH; Suo YJ; Huang ZX; Lu DC; Qin YF; Luo ZJ
Ann Endocrinol (Paris); 2015 Oct; 76(5):620-7. PubMed ID: 26514948
[TBL] [Abstract][Full Text] [Related]
33. Effects of ghrelin administration on endocrine and metabolic parameters in obese women with polycystic ovary syndrome.
Fusco A; Bianchi A; Mancini A; Milardi D; Giampietro A; Cimino V; Porcelli T; Romualdi D; Guido M; Lanzone A; Pontecorvi A; De Marinis L
J Endocrinol Invest; 2007 Dec; 30(11):948-56. PubMed ID: 18250617
[TBL] [Abstract][Full Text] [Related]
34. Association between circulating neuregulin 4 levels and metabolic, aterogenic, and AMH profile of polycystic ovary syndrome.
Kurek Eken M; Sahin Ersoy G; Yayla Abide C; Sanverdi İ; Devranoglu B; Kutlu T; Çevik Ö
J Obstet Gynaecol; 2019 Oct; 39(7):975-980. PubMed ID: 31064233
[TBL] [Abstract][Full Text] [Related]
35. Prolactin is associated with metabolic risk and cortisol in 1007 women with polycystic ovary syndrome.
Glintborg D; Altinok M; Mumm H; Buch K; Ravn P; Andersen M
Hum Reprod; 2014 Aug; 29(8):1773-9. PubMed ID: 24903198
[TBL] [Abstract][Full Text] [Related]
36. The contribution of diet, physical activity and sedentary behaviour to body mass index in women with and without polycystic ovary syndrome.
Moran LJ; Ranasinha S; Zoungas S; McNaughton SA; Brown WJ; Teede HJ
Hum Reprod; 2013 Aug; 28(8):2276-83. PubMed ID: 23771201
[TBL] [Abstract][Full Text] [Related]
37. High-sensitivity C-reactive protein (hs-CRP) levels and its relationship with components of polycystic ovary syndrome in Indian adolescent women with polycystic ovary syndrome (PCOS).
Ganie MA; Hassan S; Nisar S; Shamas N; Rashid A; Ahmed I; Douhat S; Mudassar S; Jan VM; Rashid F
Gynecol Endocrinol; 2014 Nov; 30(11):781-4. PubMed ID: 25137507
[TBL] [Abstract][Full Text] [Related]
38. Apolipoprotein A-I and B levels, dyslipidemia and metabolic syndrome in south-west Chinese women with PCOS.
Zhang J; Fan P; Liu H; Bai H; Wang Y; Zhang F
Hum Reprod; 2012 Aug; 27(8):2484-93. PubMed ID: 22674204
[TBL] [Abstract][Full Text] [Related]
39. Insulin, somatotropic, and luteinizing hormone axes in lean and obese women with polycystic ovary syndrome: common and distinct features.
Morales AJ; Laughlin GA; Bützow T; Maheshwari H; Baumann G; Yen SS
J Clin Endocrinol Metab; 1996 Aug; 81(8):2854-64. PubMed ID: 8768842
[TBL] [Abstract][Full Text] [Related]
40. Racial and ethnic differences in the metabolic response of polycystic ovary syndrome.
Ezeh U; Ida Chen YD; Azziz R
Clin Endocrinol (Oxf); 2020 Aug; 93(2):163-172. PubMed ID: 32286715
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
